244 related articles for article (PubMed ID: 4144064)
1. Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.
Aenishänslin W; Pestalozzi-Kerpel J; Dubach UC; Imhof PR; Turri M
Eur J Clin Pharmacol; 1972 Jun; 4(3):177-81. PubMed ID: 4144064
[No Abstract] [Full Text] [Related]
2. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
Kirch W; von Gizycki C
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
[No Abstract] [Full Text] [Related]
3. Beta-adrenergic receptor blocking drugs in hypertension.
Simpson FO
Drugs; 1974; 7(1):85-105. PubMed ID: 4152167
[No Abstract] [Full Text] [Related]
4. [Role of urapidil in the treatment of arterial hypertension].
Ol'binskaia LI; Vertkin AL; Gogin EE; Zadionchenko VS; Martynov AI; Martynov IV; Kolassa N; Man int Vel'd AI; Sidorenko BA; Belova EV
Kardiologiia; 1992 Apr; 32(4):99-111. PubMed ID: 1357221
[No Abstract] [Full Text] [Related]
5. [Beta adrenergic drugs in arterial hypertension].
Gysling E
Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
[No Abstract] [Full Text] [Related]
6. Vasodilating versus first-generation β-blockers for cardiovascular protection.
Fares H; Lavie CJ; Ventura HO
Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
[TBL] [Abstract][Full Text] [Related]
7. Reduction of side effects of vasodilators with beta-blockers. synergistic effect of beta-blockers in combination with vasodilators in reducing blood pressure.
Aust N Z J Med; 1976 Aug; 6(3 Suppl):94-6. PubMed ID: 14628
[No Abstract] [Full Text] [Related]
8. Clinical experience with dual-acting drugs in hypertension.
Rahn KH
Clin Investig; 1992; 70 Suppl 1():S39-42. PubMed ID: 1350483
[TBL] [Abstract][Full Text] [Related]
9. [Antihypertensive therapy using beta receptor blockers].
Meurer KA
Dtsch Med Wochenschr; 1975 Oct; 100(42):2161-2. PubMed ID: 240664
[No Abstract] [Full Text] [Related]
10. Influence of salt intake on the antihypertensive effect of carvedilol.
Ruilope LM; Lahera V
J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive medications.
Slagle MA
South Med J; 2001 Nov; 94(11):1071-3. PubMed ID: 11780676
[No Abstract] [Full Text] [Related]
12. Drug therapy in childhood hypertension.
Roy LP
Indian J Pediatr; 1988; 55(3):359-71. PubMed ID: 2906330
[No Abstract] [Full Text] [Related]
13. [Arterial hypertension: therapeutic trends].
Di Natale M
Clin Ter; 1988 Jan; 124(1):47-54. PubMed ID: 2904320
[No Abstract] [Full Text] [Related]
14. Beta-blockers for hypertension: are they going out of style?
Che Q; Schreiber MJ; Rafey MA
Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
[No Abstract] [Full Text] [Related]
16. Beta blockers in primary hypertension: Do age and type of beta-blocker matter?
Lindholm LH; Carlberg B; Samuelsson O
J Hypertens; 2006 Nov; 24(11):2143-5. PubMed ID: 17053530
[No Abstract] [Full Text] [Related]
17. Practical clinical pharmacology of antihypertensive drugs.
Gifford RW
Cardiovasc Clin; 1975; 7(1):143-56. PubMed ID: 238740
[No Abstract] [Full Text] [Related]
18. Tailoring the antihypertensive drug regimen.
Amadio P; Cummings DM; Amadio PB
Am Fam Physician; 1986 Aug; 34(2):157-70. PubMed ID: 2875638
[TBL] [Abstract][Full Text] [Related]
19. Beta-blockers: no longer an option for uncomplicated hypertension.
Bangalore S; Kamalakkannan G; Messerli FH
Curr Cardiol Rep; 2007 Nov; 9(6):441-6. PubMed ID: 17999868
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentration and antihypertensive effect of beta-receptor blockers.
Hitzenberger G
Cardiology; 1979; 64 Suppl 1():14-9. PubMed ID: 42485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
